Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Correction: Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma.

Short SP, Barrett CW, Stengel KR, Revetta FL, Choksi YA, Coburn LA, Lintel MK, McDonough EM, Washington MK, Wilson KT, Prokhortchouk E, Chen X, Hiebert SW, Reynolds AB, Williams CS.

Oncogene. 2019 May 8. doi: 10.1038/s41388-019-0829-z. [Epub ahead of print]

PMID:
31068667
2.

Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma.

Short SP, Barrett CW, Stengel KR, Revetta FL, Choksi YA, Coburn LA, Lintel MK, McDonough EM, Washington MK, Wilson KT, Prokhortchouk E, Chen X, Hiebert SW, Reynolds AB, Williams CS.

Oncogene. 2019 Mar 11. doi: 10.1038/s41388-019-0777-7. [Epub ahead of print] Erratum in: Oncogene. 2019 May 8;:.

PMID:
30858547
3.

The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5' and 3' ends of genes.

Sampathi S, Acharya P, Zhao Y, Wang J, Stengel KR, Liu Q, Savona MR, Hiebert SW.

Nucleic Acids Res. 2019 Feb 26. pii: gkz127. doi: 10.1093/nar/gkz127. [Epub ahead of print]

4.

BET inhibitors reduce cell size and induce reversible cell cycle arrest in AML.

Zhang S, Zhao Y, Heaster TM, Fischer MA, Stengel KR, Zhou X, Ramsey H, Zhou MM, Savona MR, Skala MC, Hiebert SW.

J Cell Biochem. 2018 Nov 11. doi: 10.1002/jcb.28005. [Epub ahead of print]

PMID:
30417424
5.

Deacetylase activity of histone deacetylase 3 is required for productive VDJ recombination and B-cell development.

Stengel KR, Barnett KR, Wang J, Liu Q, Hodges E, Hiebert SW, Bhaskara S.

Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8608-8613. doi: 10.1073/pnas.1701610114. Epub 2017 Jul 24.

6.

Identification of active miRNA promoters from nuclear run-on RNA sequencing.

Liu Q, Wang J, Zhao Y, Li CI, Stengel KR, Acharya P, Johnston G, Hiebert SW, Shyr Y.

Nucleic Acids Res. 2017 Jul 27;45(13):e121. doi: 10.1093/nar/gkx318.

7.

CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.

Jiang Y, Ortega-Molina A, Geng H, Ying HY, Hatzi K, Parsa S, McNally D, Wang L, Doane AS, Agirre X, Teater M, Meydan C, Li Z, Poloway D, Wang S, Ennishi D, Scott DW, Stengel KR, Kranz JE, Holson E, Sharma S, Young JW, Chu CS, Roeder RG, Shaknovich R, Hiebert SW, Gascoyne RD, Tam W, Elemento O, Wendel HG, Melnick AM.

Cancer Discov. 2017 Jan;7(1):38-53. doi: 10.1158/2159-8290.CD-16-0975. Epub 2016 Oct 12.

8.

High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML.

Zhao Y, Liu Q, Acharya P, Stengel KR, Sheng Q, Zhou X, Kwak H, Fischer MA, Bradner JE, Strickland SA, Mohan SR, Savona MR, Venters BJ, Zhou MM, Lis JT, Hiebert SW.

Cell Rep. 2016 Aug 16;16(7):2003-16. doi: 10.1016/j.celrep.2016.07.032. Epub 2016 Aug 4.

9.

Histone Deacetylase 3 Is Required for Efficient T Cell Development.

Stengel KR, Zhao Y, Klus NJ, Kaiser JF, Gordy LE, Joyce S, Hiebert SW, Summers AR.

Mol Cell Biol. 2015 Nov;35(22):3854-65. doi: 10.1128/MCB.00706-15. Epub 2015 Aug 31.

10.

Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells.

Dutta P, Sager HB, Stengel KR, Naxerova K, Courties G, Saez B, Silberstein L, Heidt T, Sebas M, Sun Y, Wojtkiewicz G, Feruglio PF, King K, Baker JN, van der Laan AM, Borodovsky A, Fitzgerald K, Hulsmans M, Hoyer F, Iwamoto Y, Vinegoni C, Brown D, Di Carli M, Libby P, Hiebert SW, Scadden DT, Swirski FK, Weissleder R, Nahrendorf M.

Cell Stem Cell. 2015 May 7;16(5):477-87. doi: 10.1016/j.stem.2015.04.008.

11.

Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy.

Stengel KR, Hiebert SW.

Antioxid Redox Signal. 2015 Jul 1;23(1):51-65. doi: 10.1089/ars.2014.5915. Epub 2014 Jun 26. Review.

12.

HDAC3 is essential for DNA replication in hematopoietic progenitor cells.

Summers AR, Fischer MA, Stengel KR, Zhao Y, Kaiser JF, Wells CE, Hunt A, Bhaskara S, Luzwick JW, Sampathi S, Chen X, Thompson MA, Cortez D, Hiebert SW.

J Clin Invest. 2013 Jul;123(7):3112-23. doi: 10.1172/JCI60806. Epub 2013 Jun 10.

13.

Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma.

Wells CE, Bhaskara S, Stengel KR, Zhao Y, Sirbu B, Chagot B, Cortez D, Khabele D, Chazin WJ, Cooper A, Jacques V, Rusche J, Eischen CM, McGirt LY, Hiebert SW.

PLoS One. 2013 Jul 22;8(7):e68915. doi: 10.1371/journal.pone.0068915. Print 2013.

14.

Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters.

Barrett CW, Smith JJ, Lu LC, Markham N, Stengel KR, Short SP, Zhang B, Hunt AA, Fingleton BM, Carnahan RH, Engel ME, Chen X, Beauchamp RD, Wilson KT, Hiebert SW, Reynolds AB, Williams CS.

PLoS One. 2012;7(12):e51205. doi: 10.1371/journal.pone.0051205. Epub 2012 Dec 12.

15.

Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting.

Stengel KR, Zheng Y.

PLoS One. 2012;7(6):e37317. doi: 10.1371/journal.pone.0037317. Epub 2012 Jun 18.

16.

Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context.

Dean JL, McClendon AK, Stengel KR, Knudsen ES.

Oncogene. 2010 Jan 7;29(1):68-80. doi: 10.1038/onc.2009.313. Epub 2009 Oct 5.

PMID:
19802012
17.

Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.

Stengel KR, Thangavel C, Solomon DA, Angus SP, Zheng Y, Knudsen ES.

J Biol Chem. 2009 Jul 17;284(29):19265-71. doi: 10.1074/jbc.M808740200. Epub 2009 Mar 11.

18.
19.

RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents.

Stengel KR, Dean JL, Seeley SL, Mayhew CN, Knudsen ES.

Cell Cycle. 2008 Apr 15;7(8):1095-103. Epub 2008 Feb 11.

PMID:
18414045

Supplemental Content

Loading ...
Support Center